Raymond Fujikawa Sells 6,364 Shares of Orthofix International N.V. (NASDAQ:OFIX) Stock
Orthofix International N.V. (NASDAQ:OFIX) insider Raymond Fujikawa sold 6,364 shares of Orthofix International N.V. stock in a transaction dated Thursday, August 10th. The shares were sold at an average price of $47.06, for a total value of $299,489.84. Following the transaction, the insider now owns 31,084 shares of the company’s stock, valued at approximately $1,462,813.04. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
Orthofix International N.V. (NASDAQ:OFIX) traded up 1.17% during trading on Monday, hitting $47.50. 87,905 shares of the company’s stock traded hands. The company’s 50 day moving average is $45.69 and its 200-day moving average is $41.05. Orthofix International N.V. has a 12 month low of $32.51 and a 12 month high of $49.60. The stock has a market cap of $863.08 million, a P/E ratio of 111.24 and a beta of 0.25.
Orthofix International N.V. (NASDAQ:OFIX) last posted its quarterly earnings results on Monday, August 7th. The medical device company reported $0.42 EPS for the quarter, beating the Zacks’ consensus estimate of $0.41 by $0.01. Orthofix International N.V. had a net margin of 1.88% and a return on equity of 9.96%. The firm had revenue of $108.90 million for the quarter, compared to analysts’ expectations of $102.94 million. During the same quarter in the prior year, the company posted $0.41 earnings per share. The business’s revenue for the quarter was up 4.6% on a year-over-year basis. On average, analysts predict that Orthofix International N.V. will post $1.55 earnings per share for the current year.
COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another website, it was stolen and republished in violation of international copyright and trademark laws. The correct version of this piece of content can be read at https://www.watchlistnews.com/raymond-fujikawa-sells-6364-shares-of-orthofix-international-n-v-nasdaqofix-stock/1488108.html.
Several large investors have recently bought and sold shares of the stock. Wellington Management Group LLP purchased a new stake in Orthofix International N.V. during the first quarter worth approximately $20,021,000. Vanguard Group Inc. boosted its stake in Orthofix International N.V. by 18.6% in the first quarter. Vanguard Group Inc. now owns 1,815,948 shares of the medical device company’s stock worth $69,278,000 after buying an additional 284,482 shares during the last quarter. Teachers Advisors LLC boosted its stake in Orthofix International N.V. by 676.2% in the first quarter. Teachers Advisors LLC now owns 276,340 shares of the medical device company’s stock worth $10,542,000 after buying an additional 240,740 shares during the last quarter. Norges Bank purchased a new stake in Orthofix International N.V. during the fourth quarter worth approximately $5,664,000. Finally, Paradice Investment Management LLC purchased a new stake in Orthofix International N.V. during the second quarter worth approximately $6,642,000. Hedge funds and other institutional investors own 97.31% of the company’s stock.
OFIX has been the subject of a number of analyst reports. Zacks Investment Research upgraded Orthofix International N.V. from a “sell” rating to a “hold” rating in a research note on Thursday, July 6th. Langenberg & Company reiterated a “buy” rating and set a $53.25 price target on shares of Orthofix International N.V. in a research note on Wednesday, June 14th. Ladenburg Thalmann Financial Services initiated coverage on Orthofix International N.V. in a research note on Wednesday, June 14th. They set a “buy” rating and a $53.25 price target for the company. BTIG Research initiated coverage on Orthofix International N.V. in a research note on Wednesday, June 21st. They set a “buy” rating and a $52.00 price target for the company. Finally, TheStreet upgraded Orthofix International N.V. from a “c+” rating to a “b-” rating in a research note on Tuesday, August 8th. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the stock. Orthofix International N.V. presently has an average rating of “Buy” and a consensus target price of $52.75.
About Orthofix International N.V.
Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.
Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.